Neogen Corp (STU:NG2)
€ 8.24 +0.060 (+0.73%) Market Cap: 2.19 Bil Enterprise Value: 2.72 Bil PE Ratio: 0 PB Ratio: 0.98 GF Score: 71/100

Q3 2025 Neogen Corp Earnings Call Transcript

Apr 09, 2025 / 12:00PM GMT
Release Date Price: €6.2 (-13.29%)

Key Points

Positve
  • Neogen Corp (NEOG) achieved a 7% core revenue growth in its Food Safety segment, indicating a solid underlying business despite market challenges.
  • The company successfully completed the refinancing of its Term Loan A, extending the maturity by close to three years and realizing 60 basis points of interest rate savings.
  • Neogen Corp (NEOG) has made significant progress in the integration of its transformational acquisition, with sample collection recovering to prior production levels.
  • The company is focusing on its differentiated bovine genomics product offering, which has shown growth despite challenges in other areas of the genomics business.
  • Neogen Corp (NEOG) is taking actions to accelerate the building of a more profitable and focused business, with potential portfolio actions expected to be accretive to margins and prioritized for debt repayment.
Negative
  • Neogen Corp (NEOG) faced a challenging macroeconomic environment, with uncertainty in global trade and potential recession concerns impacting customer confidence and inventory commitments.
  • The company's third-quarter results were below expectations, with core revenue growth of only 20 basis points and a foreign currency headwind of 310 basis points.
  • The Animal Safety segment experienced a core revenue decline of 2.6%, with notable softness in China due to macroeconomic uncertainty.
  • Neogen Corp (NEOG) is dealing with challenges in its genomics business, which has been a headwind for the past seven quarters, resulting in a mid-single-digit decline in core revenue.
  • The company is updating its full-year revenue outlook to approximately $895 million, reflecting a softer market backdrop and the uncertain impact of tariffs.
Operator

Good morning, ladies and gentlemen, and welcome to the Neogen Corporation third-quarter fiscal year 2025 earnings conference call.(Operator instructions) This call is being recorded on Wednesday, April 9, 2025.

I would now like to turn the conference over to Bill Waelke, Head of Investor Relations. Please go ahead.

Bill Waelke
Neogen Corp - Investor Relations

Thank you for joining us this morning for the discussion of the third quarter of our 2025 fiscal year. I'll briefly cover the non-GAAP and forward-looking language before passing the call over to our CEO, John Adent, who will be followed by our CFO and COO, David Naemura.

Before the market opened today, we published our third quarter results as well as the presentation with both documents available in the Investor Relations section of our website. On our call this morning, we will refer to certain non-GAAP financial measures that we believe are useful in evaluating our performance.

Reconciliations of historical non-GAAP financial measures are included in our earnings release

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot